Limitless Life built a following among longevity and cognition-focused buyers with a peptide and nootropics menu and a members-only feel
doi:10.1155/2016/8201053 5
At the higher doses, results were very consistent: All participants lost at least 5% of their body weight Around 3 in 4 lost 15% or more With placebo, only around 1 in 4 lost 5% or more Phase 3 update (TRIUMPH-4, 68 weeks, topline results) In December 2025 , Eli Lilly shared early (topline) results from a larger phase 3 study (TRIUMPH-4)
Animal studies show NAC protects against pulmonary inflammation, edema, MPO activity, cellular infiltration, and cytokine elevation (TNF-, IL-6, IL-1, CXCL10) in swine influenzainduced lung injury (129)